US 11,986,412 B2
Sweden apparatus for treating GERD
Peter Forsell, Bouveret (CH)
Filed by Peter Forsell, Bouveret (CH)
Filed on May 18, 2020, as Appl. No. 16/876,330.
Application 16/876,330 is a continuation of application No. 13/146,314, granted, now 10,653,543, previously published as PCT/SE2010/050100, filed on Jan. 29, 2010.
Claims priority of application No. PCT/SE2009/000051 (WO), filed on Jan. 29, 2009; application No. 0900997-8 (SE), filed on Jul. 17, 2009; and application No. PCT/SE2009/051155 (WO), filed on Oct. 12, 2009.
Prior Publication US 2021/0000627 A1, Jan. 7, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 17/00 (2006.01); A61B 1/04 (2006.01); A61B 17/04 (2006.01); A61B 17/068 (2006.01); A61B 17/08 (2006.01); A61F 2/04 (2013.01); A61F 5/00 (2006.01); A61B 1/06 (2006.01); A61B 1/273 (2006.01); A61B 1/313 (2006.01); A61B 17/064 (2006.01); A61B 17/30 (2006.01); A61B 17/32 (2006.01); A61B 17/34 (2006.01); A61N 1/36 (2006.01)
CPC A61F 5/0083 (2013.01) [A61B 1/04 (2013.01); A61B 17/00 (2013.01); A61B 17/00234 (2013.01); A61F 2/04 (2013.01); A61F 5/003 (2013.01); A61B 1/06 (2013.01); A61B 1/2736 (2013.01); A61B 1/3132 (2013.01); A61B 2017/00278 (2013.01); A61B 2017/00561 (2013.01); A61B 2017/00818 (2013.01); A61B 2017/00827 (2013.01); A61B 17/0469 (2013.01); A61B 17/064 (2013.01); A61B 17/068 (2013.01); A61B 17/0682 (2013.01); A61B 17/08 (2013.01); A61B 2017/081 (2013.01); A61B 17/30 (2013.01); A61B 2017/306 (2013.01); A61B 2017/308 (2013.01); A61B 17/320016 (2013.01); A61B 17/3423 (2013.01); A61B 17/3474 (2013.01); A61F 2002/044 (2013.01); A61F 2002/045 (2013.01); A61F 5/0003 (2013.01); A61F 5/0013 (2013.01); A61F 2005/0016 (2013.01); A61F 2005/002 (2013.01); A61F 2005/0023 (2013.01); A61F 5/0026 (2013.01); A61F 5/0033 (2013.01); A61F 5/0036 (2013.01); A61F 5/004 (2013.01); A61F 5/0043 (2013.01); A61F 5/0046 (2013.01); A61F 5/005 (2013.01); A61F 5/0063 (2013.01); A61F 5/0069 (2013.01); A61F 5/0073 (2013.01); A61F 5/0076 (2013.01); A61F 5/0079 (2013.01); A61F 5/0086 (2013.01); A61F 5/0089 (2013.01); A61F 2250/0001 (2013.01); A61F 2250/0004 (2013.01); A61N 1/36007 (2013.01)] 10 Claims
OG exemplary drawing
 
1. An apparatus for treating reflux disease of a human patient, the apparatus comprising:
a first movement restriction device segment, and
a second movement restriction device segment,
wherein the first movement restriction device segment and the second movement restriction device segment are adapted to be directly connected to each other into an assembled, implantable movement restriction device, and
wherein the first and second movement restriction device segments have a size and shape allowing them to be invaginated by a stomach fundus wall portion of the patient and to maintain a predefined shape when assembled and invaginated by the stomach fundus wall portion, without injuring the stomach fundus wall, in a position between the patient's diaphragm and the cardia sphincter, such that movement of the cardiac notch of the patient's stomach towards the patient's diaphragm is restricted to thereby prevent the cardia from sliding through the patient's diaphragm opening into the patient's thorax, wherein the assembled movement restriction device is configured to be disassembled into its movement restriction device segments if the movement restriction device leaves its invaginated stomach position, and wherein the movement restriction device segments are adapted to separately pass through the food passageway, thereby reducing risk for causing obstruction/ileus in the patient's intestine.